← FDA DRUG APPROVALS

FDA ANDA · ANDA065400

AZITHROMYCIN

Sponsor: LUPIN

APPLICATION
ANDA065400
TYPE
ANDA
ORIGINAL APPROVAL
2015-05-15
LATEST ACTION
2021-11-22
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

AZITHROMYCINPrescription
AZITHROMYCIN EQ 600MG BASE · TABLET · ORAL

Approval history

2021-11-22Labeling · Supplement 19 · standardAP
2019-12-23Labeling · Supplement 5 · standardAP
2019-12-23Labeling · Supplement 10 · standardAP
2015-05-15OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →